Mitochondrial Enhancement Research Kit (RUO)

Description

The Mitochondrial Enhancement Research Kit combines MOTS-c (40mg) and 5-Amino-1MQ (50mg) — two compounds that approach mitochondrial function and cellular energy regulation from complementary angles: MOTS-c through mitochondria-to-nucleus retrograde signaling, and 5-Amino-1MQ through NNMT inhibition and NAD⁺ pathway conservation.

Kit Components

• MOTS-c (40mg): 16-AA mitochondria-derived peptide encoded in the mitochondrial genome. Activates AMPK, upregulates ARE/Nrf2 gene programs, improves insulin sensitivity, and coordinates mitochondrial stress responses. Circulating levels decline with age.
• 5-Amino-1MQ (50mg): NNMT inhibitor. By blocking nicotinamide N-methyltransferase, preserves the SAM pool available for other methylation reactions and shifts NAD⁺/NADH ratios toward improved mitochondrial function. Reduces lipid accumulation in adipocyte models.

Research Context

Both compounds affect mitochondrial function through different upstream mechanisms — MOTS-c through direct mitochondrial signaling peptide activity, 5-Amino-1MQ through metabolite conservation that enhances mitochondrial substrate availability. Studying them together allows researchers to investigate whether AMPK activation (MOTS-c) and NNMT inhibition (5-Amino-1MQ) produce additive or synergistic effects on mitochondrial bioenergetics, NAD⁺ levels, and metabolic phenotype.

Common Research Applications

• Mitochondria-derived peptide + NNMT inhibitor combination studies
• AMPK activation and NAD⁺ pathway conservation research
• Mitochondrial biogenesis and function optimization models
• Metabolic aging and cellular energy research

For Research Use Only. Not for human or veterinary use.